An analysis of Danish national healthcare registry data found that adults with type 2 diabetes who initiated treatment with SGLT2 inhibitors had a slightly lower risk of developing diabetic foot ...
SGLT2 inhibitors may be a better treatment option for some older, frail patients hospitalized with heart failure, according to a study presented at the 2025 annual meeting of the Heart Failure Society ...
SGLT2 inhibitors combat inflammation and slow kidney disease by elevating S-adenosylmethionine (SAM) levels, which suppress inflammatory gene activity through epigenetic modification. The benefits of ...
Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors were linked to lower risks for CKD and AKI but greater risks for albuminuria vs. GLP-1s. Risk ...
Please provide your email address to receive an email when new articles are posted on . Treatment with SGLT2 inhibitors was associated with decreased mortality but increased incidence of lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results